Japan Planning To Require More Data For ‘Advanced’ Evaluations
This article was originally published in PharmAsia News
Executive Summary
Japan’s regulatory agency, the PMDA, is planning to set up a new center to conduct more in-depth evaluations of new drugs and devices, supported by additional data from applicants.